Serum Interleukin Profile in Patients with Graves Orbithopathy

Background: Graves’ orbitopathy (GO) is considered an autoimmune condition in close relationship with Graves’ disease (GD) affecting the thyroid. Several similarities exist between the two conditions, sharing the common antigen and the characteristics of the inflammation mediated by a number of cyto...

Full description

Bibliographic Details
Main Authors:	Réti Zsuzsánna, Kun Iz, Radu Pop Corina Cristina
Format:	Article
Language:	English
Published:	Sciendo 2013-02-01
Series:	Acta Medica Marisiensis
Subjects:	graves’ orbitopathy interleukins smoking disease activity
Online Access:	https://doi.org/10.2478/amma-2013-0007

Similar Items

Factors associated with severity of orbitopathy in patients with Graves' disease
by: Tauseef Nabi, et al.
Published: (2020-01-01)

Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
by: David J. Russell, et al.
Published: (2017-09-01)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
by: Dorota Walasik-Szemplińska, et al.
Published: (2019-12-01)

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
by: Neeraja Boddu, et al.
Published: (2017-07-01)

Graves′ orbitopathy: Management of difficult cases
by: Wilmar M Wiersinga
Published: (2012-01-01)

Evaluation of Quality of Life in the Brazilian Graves' Disease Population: Focus on Mild and Moderate Graves' Orbitopathy Patients
by: Danilo Villagelin, et al.
Published: (2019-04-01)

Clinical assessment of patients with Graves' orbitopathy
by: Nedeljković-Beleslin Biljana
Published: (2011-01-01)

Graves’ orbitopathy: lessons from Representational Art
by: Francesco Trimarchi, et al.
Published: (2021-05-01)

Current Knowledge on Graves’ Orbitopathy
by: Katarzyna Gontarz-Nowak, et al.
Published: (2021-12-01)

Epidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
by: Luigi Bartalena, et al.
Published: (2020-11-01)

Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
by: Tülay Şimşek, et al.
Published: (2017-01-01)

Risk factors for thyroid-associated orbitopathy due to Graves' disease
by: Tauseef Nabi, et al.
Published: (2021-01-01)

Puls-therapy with metilprednisolon in Grave's orbitopathy
Published: (2012-12-01)

Clinical, Hormonal, and Ultrasound Characteristics of Patients with Newly Diagnosed Graves’ Disease And Different Thyroid Antibody Profiles
by: Mekova R., et al.
Published: (2019-05-01)

Safety of different types of methylprednisolone puls-therapy in the treatment of Graves' orbitopathy
Published: (2012-09-01)

Clinical outcomes of radiotherapy as initial local therapy for Graves’ ophthalmopathy and predictors of the need for post-radiotherapy decompressive surgery
by: Prabhu Roshan S, et al.
Published: (2012-06-01)

Exophthalmos in a young woman with no Graves’ disease – a case report of IgG4-related orbitopathy
by: Annamaria Erdei, et al.
Published: (2018-01-01)

Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves′ orbitopathy: A randomized controlled trial
by: Ajitesh Roy, et al.
Published: (2015-01-01)

Related quality of life questionnaire specific to dysthyroid ophthalmopathy evaluated in a population of patients with Graves’ disease
by: Laura Carolina Delfino, et al.
Published: (2017-02-01)

TSH-receptor antibodies may prevent bone loss in pre- and postmenopausal women with Graves' disease and Graves' orbitopathy
by: Mira Siderova, et al.

Treatment with Intravenous Methylprednisolone in Patients with Graves’ Orbitopathy Significantly Affects Adrenal Function: Assessment of Serum, Salivary Cortisol and Serum Dehydroepiandrosterone Sulfate
by: Katarzyna Pelewicz, et al.
Published: (2020-10-01)

Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
by: P. Perros, et al.
Published: (2017-04-01)

Unusual onset of thyroid associated orbitopathy during pregnancy: case report and review of literature
by: Janos K. Aranyosi, et al.
Published: (2020-12-01)

Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
by: Giulia Lanzolla, et al.
Published: (2020-01-01)

Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
by: Laura Penta, et al.
Published: (2019-01-01)

Endoscopic Orbital Decompression for Graves’ Orbitopathy – A Vietnam Study
by: Pham TMH, et al.
Published: (2021-04-01)

Modulating gut microbiota in a mouse model of Graves’ orbitopathy and its impact on induced disease
by: Sajad Moshkelgosha, et al.
Published: (2021-02-01)

Psycho-Cognitive Profile and NGF and BDNF Levels in Tears and Serum: A Pilot Study in Patients with Graves’ Disease
by: Bruscolini, A., et al.
Published: (2023)

The clinical tomographic interconnection in diplopia of patients with Graves' orbitopathy
Published: (2012-03-01)

Efficacy of orbital radiotherapy in moderate-to-severe active graves’ orbitopathy including long-lasting disease: a retrospective analysis
by: Jin Hwa Choi, et al.
Published: (2020-09-01)

Gut microbiota in experimental murine model of Graves’ orbitopathy established in different environments may modulate clinical presentation of disease
by: Giulia Masetti, et al.
Published: (2018-05-01)

Clinical utility of TSH receptor antibody levels in Graves’ orbitopathy: a comparison of two TSH receptor antibody immunoassays
by: Gabriela A. Bluszcz, et al.
Published: (2018-12-01)

Immunological Features of Paranasal Sinus Mucosa in Patients with Graves’ Orbitopathy
by: Yi Lu, et al.
Published: (2021-02-01)

Topical Treatment of Elevated Intraocular Pressure in Patients with Graves’ Orbitopathy
by: Magdalena Gumińska, et al.
Published: (2020-12-01)

Selenium in the Treatment of Graves’ Hyperthyroidism and Eye Disease
by: Giulia Lanzolla, et al.
Published: (2021-01-01)

Clinicoradiologic Relationships in Case of Grave's Orbitopathy
Published: (2009-03-01)

Color Doppler imaging of the superior ophthalmic vein in patients with Graves' orbitopathy before and after treatment of congestive disease
by: Mário L. R. Monteiro, et al.
Published: (2011-01-01)

Severe Graves' disease‐associated orbitopathy: A rare case of frontal bone hemangioma
by: Ahmad Alamri, et al.
Published: (2021-02-01)

Endoscopic and transcaruncular medial wall decompression in unilateral graves’ orbitopathy: a multicenter randomized study
by: Mahmoud A. El-Samkary, et al.
Published: (2017-07-01)